Live Breaking News & Updates on Xeris Stock Options

Stay updated with breaking news from Xeris stock options. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Xeris Pharmaceuticals, Inc.: Xeris Pharmaceuticals Provides Announcement Under the Irish Takeover Rules for Relevant Securities in Issue

Xeris Pharmaceuticals, Inc.: Xeris Pharmaceuticals Provides Announcement Under the Irish Takeover Rules for Relevant Securities in Issue
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

New York , United States , Allison Wey , Strongbridge Biopharma , Xeris Pharmaceuticals Inc , Xeris Biopharma Holdings Inc , Irish Takeover Panel , Wells Mergersub Inc , Corporate Communications , International Securities Identification Number , Xeris Pharmaceuticals , Irish Takeover Panel Act , Takeover Rules , Irish Takeover Rules , Nasdaq Global Select Market , Xeris Stock Options , Xeris Restricted Stock Units , Xeris Warrants , Convertible Senior Notes , Xeris Convertible , Xeris Stock Option , Xeris Restricted Stock Unit , Xeris Warrant , Xeris Convertible Notes , Transaction Agreement , Xeris Biopharma Holdings ,

Rule 2.5 Announcement: Xeris Pharmaceuticals, Inc. to Acquire Strongbridge Biopharma plc in Stock and CVR Transaction, Creating an Innovative Leader in Endocrinology and Rare Diseases

Rule 2.5 Announcement: Xeris Pharmaceuticals, Inc. to Acquire Strongbridge Biopharma plc in Stock and CVR Transaction, Creating an Innovative Leader in Endocrinology and Rare Diseases
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION
THIS ANNOUNCEMENT IS BEING MADE PURSUANT TO RULE 2.5 OF THE IRISH TAKEOVER RULES
FOR IMMEDIATE RELEASE
Transaction Creates Fast-Growing Biopharmaceutical Company with Two Commercial Assets and Robust Clinical Pipeline with Multiple Near-term Inflection Points
Diversifies Revenue Base with Two Rapidly Growing Brands in Xeris Gvoke® and Strongbridge s KEVEYIS® ....

New York , United States , District Of Columbia , State Of New York , Jeffreyw Sherman , Strongbridge Rsus , Andy Brimmer , Meagher Flom , Marten Steen , Joele Frank , Paulr Edick , Paul Edick , Allison Wey , Lindsay Rocco , Garheng Kong , Johnh Johnson , Strongbridge Biopharma , Wilkinson Brimmer Katcher , John Johnson , Development Pipeline , Xeris Party , Court Meeting Resolution , Registrar Of Companies , Strongbridge Us Inc , Us Food Drug Administration Orange Book , Court Meeting ,